Squire Patton Boggs has advised Aliter Capital LLP, a specialist investor focused on small to mid-sized UK Support Services businesses, on its investment in FingerPrint Global Limited.
The team advising Aliter was led by Corporate partner Paul Mann, and included James Thompson, Nathan Bentley and Olivia Baccarella, with Emma Perez providing tax advice.
FingerPrint is a provider of specialist audit and lifecycle tracking ‘Track & Trace’ solutions related to the sterilisation and decontamination of surgical instruments within clinical environments.
This represents Aliter’s second investment within its ‘Halcyon’ strategy, which is focused on creating a market leading UK-based integrated healthcare-focused software and data analytics group. FingerPrint joins existing Aliter portfolio company Net Solving, a digital health data analytics platform, a deal in which Squire Patton Boggs also advised Aliter.
Paul Mann said: “We are pleased to support Aliter as it continues to develop its Halcyon strategy. There are exciting opportunities in the healthcare sector and Aliter is well-placed to drive growth across the group with its deep industrial expertise and broad networks, and also through its plans to make complementary acquisitions in the future.”